GSK, Green Cross and SK are ambitious to lead in the tetravalent influenza market

Published: 2015-04-27 13:47:59

Updated: 2015-04-27 14:12:33

GSK announced on the 22^nd that it would launch the domestically first tetravalent influenza vaccine ‘Fluarix Tetra.’ Green Cross and SK Chemicals are also expected to launch tetravalent influenzas by the second half of the year at the earliest. It is forecasted that competition for tetravalent influenzas is going to be fierce in the upcoming 2015-2016 season.

In the U.S., it is observed that t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.